Vor Biopharma Inc. Common Stock VOR
HEALTHCARE · BIOTECHNOLOGYi
Market dataready · fetched 2026-11-12T01:16:22.975Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T21:00:08.003338458Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-12T01:16:22.356389+00:00
Vor Biopharma Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 25.24 | 150.8% | 28.0% | 17.04 | 141.7% | 17.9% |
| 25Δ | 23.62 | 128.0% | 20.2% | 17.83 | 125.3% | 14.3% |
| 30Δ | 22.39 | 115.8% | 14.8% | 18.35 | 113.7% | 12.1% |
| 35Δ | 21.95 | 132.7% | 14.4% | 18.88 | 102.0% | 9.8% |
| 40Δ | 21.51 | 149.6% | 14.0% | 19.40 | 90.3% | 7.5% |
| 45Δ | 21.07 | 166.6% | 13.6% | 19.92 | 78.7% | 5.3% |
| 50Δ | 20.63 | 183.5% | 13.3% | 20.33 | 77.9% | 4.5% |
| 55Δ | 20.19 | 200.5% | 12.9% | 20.71 | 79.1% | 3.9% |
| 60Δ | 19.60 | 200.0% | 11.4% | 21.10 | 80.2% | 3.4% |
| 65Δ | 18.91 | 186.5% | 9.1% | 21.48 | 81.4% | 2.9% |
| 70Δ | 18.22 | 173.1% | 6.7% | 21.87 | 82.6% | 2.3% |
| 75Δ | 17.53 | 159.6% | 4.4% | 22.25 | 83.7% | 1.8% |
| 80Δ | 15.86 | 203.1% | 3.8% | |||
20Δ
- Pseudo strike
- 25.24
- IV
- 150.8%
- B/E move
- 28.0%
- Pseudo strike
- 17.04
- IV
- 141.7%
- B/E move
- 17.9%
25Δ
- Pseudo strike
- 23.62
- IV
- 128.0%
- B/E move
- 20.2%
- Pseudo strike
- 17.83
- IV
- 125.3%
- B/E move
- 14.3%
30Δ
- Pseudo strike
- 22.39
- IV
- 115.8%
- B/E move
- 14.8%
- Pseudo strike
- 18.35
- IV
- 113.7%
- B/E move
- 12.1%
35Δ
- Pseudo strike
- 21.95
- IV
- 132.7%
- B/E move
- 14.4%
- Pseudo strike
- 18.88
- IV
- 102.0%
- B/E move
- 9.8%
40Δ
- Pseudo strike
- 21.51
- IV
- 149.6%
- B/E move
- 14.0%
- Pseudo strike
- 19.40
- IV
- 90.3%
- B/E move
- 7.5%
45Δ
- Pseudo strike
- 21.07
- IV
- 166.6%
- B/E move
- 13.6%
- Pseudo strike
- 19.92
- IV
- 78.7%
- B/E move
- 5.3%
50Δ
- Pseudo strike
- 20.63
- IV
- 183.5%
- B/E move
- 13.3%
- Pseudo strike
- 20.33
- IV
- 77.9%
- B/E move
- 4.5%
55Δ
- Pseudo strike
- 20.19
- IV
- 200.5%
- B/E move
- 12.9%
- Pseudo strike
- 20.71
- IV
- 79.1%
- B/E move
- 3.9%
60Δ
- Pseudo strike
- 19.60
- IV
- 200.0%
- B/E move
- 11.4%
- Pseudo strike
- 21.10
- IV
- 80.2%
- B/E move
- 3.4%
65Δ
- Pseudo strike
- 18.91
- IV
- 186.5%
- B/E move
- 9.1%
- Pseudo strike
- 21.48
- IV
- 81.4%
- B/E move
- 2.9%
70Δ
- Pseudo strike
- 18.22
- IV
- 173.1%
- B/E move
- 6.7%
- Pseudo strike
- 21.87
- IV
- 82.6%
- B/E move
- 2.3%
75Δ
- Pseudo strike
- 17.53
- IV
- 159.6%
- B/E move
- 4.4%
- Pseudo strike
- 22.25
- IV
- 83.7%
- B/E move
- 1.8%
80Δ
- Pseudo strike
- 15.86
- IV
- 203.1%
- B/E move
- 3.8%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 106.46% |
Biotechnology
VRDN
Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients with serious illnesses. The company is headquartered in Boulder, Colorado.
More →VRTX
Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.
More →VSTM
Verastem, Inc., a developing-stage biopharmaceutical company focused on developing and commercializing life-enhancing drugs for cancer patients. The company is headquartered in…
More →VYGR
Voyager Therapeutics, Inc., a clinical-stage gene therapy company, is focused on developing treatments for patients with severe neurological diseases. The company is headquartered…
More →WHWK
Description unavailable
More →WVE
Description unavailable
More →